Ad is loading...
DALVX
Price
$20.89
Change
-$0.07 (-0.33%)
Updated
Nov 15 closing price
VIVIX
Price
$68.70
Change
-$0.26 (-0.38%)
Updated
Nov 15 closing price
Ad is loading...

DALVX vs VIVIX

Header iconDALVX vs VIVIX Comparison
Open Charts DALVX vs VIVIXBanner chart's image
Dunham Large Cap Value A
Price$20.89
Change-$0.07 (-0.33%)
VolumeN/A
CapitalizationN/A
Vanguard Value Index I
Price$68.70
Change-$0.26 (-0.38%)
VolumeN/A
CapitalizationN/A
DALVX vs VIVIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
DALVX vs. VIVIX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DALVX is a Buy and VIVIX is a StrongSell.

FUNDAMENTALS
Fundamentals
VIVIX has more cash in the bank: 184B vs. DALVX (160M). VIVIX pays higher dividends than DALVX: VIVIX (2.37) vs DALVX (0.93). DALVX was incepted earlier than VIVIX: DALVX (18 years) vs VIVIX (26 years). DALVX is a more actively managed with annual turnover of: 29.00 vs. VIVIX (10.00). DALVX has a lower initial minimum investment than VIVIX: DALVX (5000) vs VIVIX (5000000). VIVIX (25.54) and DALVX (24.36) have marching annual gain over last year. VIVIX return over 5 years is better than : 50.79 vs. DALVX (42.15).
DALVXVIVIXDALVX / VIVIX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence18 years26 years-
Gain YTD20.40317.922114%
Front LoadN/AN/A-
Min. Initial Investment500050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets160M184B0%
Annual Yield % from dividends0.932.3739%
Returns for 1 year24.3625.5495%
Returns for 3 years8.4721.5739%
Returns for 5 years42.1550.7983%
Returns for 10 years35.76110.5032%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EXR164.561.13
+0.69%
Extra Space Storage
PALT1.83N/A
N/A
Paltalk
AOMR9.80-0.06
-0.61%
Angel Oak Mortgage REIT
DLO9.89-0.31
-3.04%
DLocal Limited
GYRE13.12-0.72
-5.20%
Gyre Therapeutics